This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Kocijančič A. Smernice za odkrivanje in zdravljenje osteoporoze. Zdrav Vestn. 2002;71:571.KocijančičA.Smernice za odkrivanje in zdravljenje osteoporozeZdrav Vestn.200271571Search in Google Scholar
Prevention and management of osteoporosis: report of a WHO Scientific Group. WHO Technical Report Series; 921. Geneva: World Health Organization, 2003.Prevention and management of osteoporosis: report of a WHO Scientific GroupWHO Technical Report Series921GenevaWorld Health Organization2003Search in Google Scholar
Riggs BL, Melton LJ, Robb RA, Camp JJ, Atkinson EJ, McDaniel L, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008;23:205-14.17937534RiggsBLMeltonLJRobbRACampJJAtkinsonEJMcDanielLA population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and menJ Bone Miner Res.2008232051410.1359/jbmr.071020Search in Google Scholar
Lindsay R. Prevention and treatment of osteoporosis. Lancet. 1993;341:801-5.809600910.1016/0140-6736(93)90571-WLindsayR.Prevention and treatment of osteoporosisLancet.19933418015Search in Google Scholar
Franič D. New aspects in diagnosis and treatment of osteoporosis. Zdrav Vestn. 2009;78:143-50.FraničD.New aspects in diagnosis and treatment of osteoporosisZdrav Vestn.20097814350Search in Google Scholar
Kocjan T, Preželj J, Pfeifer M, Jensterle Sever M, Čokolič M, Zavratnik A. Smernice za odkrivanje in zdravljenje osteoporoze. Zdrav Vestn. 2013;82:207-17.KocjanTPreželjJPfeiferMJensterle SeverMČokoličMZavratnikA.Smernice za odkrivanje in zdravljenje osteoporozeZdrav Vestn.20138220717Search in Google Scholar
Bolland MJ, Grey A, Reid IR. Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis? Climacteric. 2015;18(Suppl 2):22-31.10.3109/13697137.2015.109826626473773BollandMJGreyAReidIR.Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?Climacteric2015182223126473773Open DOISearch in Google Scholar
Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA. 2003;290:1729-38.10.1001/jama.290.13.172914519707CauleyJARobbinsJChenZCummingsSRJacksonRDLaCroixAZEffects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trialJAMA.200329017293814519707Open DOISearch in Google Scholar
Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SAA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;91:1701-12.AndersonGLLimacherMAssafARBassfordTBeresfordSAABlackHEffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trialJAMA.200491170112Search in Google Scholar
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;88:321-33.RossouwJEAndersonGLPrenticeRLLaCroixAZKooperbergCStefanickMLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA.20028832133Search in Google Scholar
Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465-77.17405972RossouwJEPrenticeRLMansonJEWuLBaradDBarnabeiVMPostmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopauseJAMA.200729714657710.1001/jama.297.13.146517405972Search in Google Scholar
Kocjan T, Franič D. Osteoporoza in nadomestno hormonsko zdravljenje. Zdrav Vestn. 2008;77(Suppl 3):43-8.KocjanTFraničD.Osteoporoza in nadomestno hormonsko zdravljenjeZdrav Vestn2008773438Search in Google Scholar
de Villiers TJ. The role of menopausal hormone therapy in the management of osteoporosis. Climacteric. 2015; 18(Suppl 2):19-21. 10.3109/13697137.2015.1099806.26474003de VilliersTJ.The role of menopausal hormone therapy in the management of osteoporosisClimacteric2015182192110.3109/13697137.2015.109980626474003Open DOISearch in Google Scholar
Baber RJ, Panay N, Fenton A, IMS Writing Group. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19:109-50. 10.3109/13697137.2015.1129166.26872610BaberRJPanayNFentonAIMS Writing Group2016IMS recommendations on women’s midlife health and menopause hormone therapyClimacteric.2016191095010.3109/13697137.2015.112916626872610Open DOISearch in Google Scholar
Kanis JA, Harvey NC, Johansson H, Oden A, Leslie WD, McCloskey EV. FRAX and fracture prediction without bone mineral density. Climacteric. 2015; 18(Suppl 2):2-9. 10.3109/13697137.2015.1092342.26489076KanisJAHarveyNCJohanssonHOdenALeslieWDMcCloskeyEV.FRAX and fracture prediction without bone mineral densityClimacteric.20151822910.3109/13697137.2015.109234226489076Open DOISearch in Google Scholar
Kanis JA, Johnel O. Requirements for DXA for the management of osteoporoisi in Europe. Osteoporos Int. 2005;16:229-38.1561899610.1007/s00198-004-1811-2KanisJAJohnelO.Requirements for DXA for the management of osteoporoisi in EuropeOsteoporos Int.2005162293815618996Search in Google Scholar
Komadina R, Senekovič V, Dolenc I, Andoljšek M,Grabljevec K, Venišek K, et al. Priporočila za zdravljenje zloma kolka v Sloveniji. Zdrav Vestn. 2012;81:183-92.KomadinaRSenekovičVDolencIAndoljšekMGrabljevecKVenišekKPriporočila za zdravljenje zloma kolka v SlovenijiZdrav Vestn.20128118392Search in Google Scholar
Kocjan T. Zlomkolka – najpomembnejši zaplet ostoporoze. ISIS. 2010;19:64-6.KocjanT.Zlomkolka – najpomembnejši zaplet ostoporozeISIS.201019646Search in Google Scholar
Ilic Stojanovic M, Vuceljic M, Lazovic M, Gajic N, Radosavljevic D, Nikolic A, et al. Bone mineral density at different sites and vertebral fractures in Serbian postmenopausal women. Climacteric. 2017;20:37-43. 10.1080/13697137.2016.1253054.27860483Ilic StojanovicMVuceljicMLazovicMGajicNRadosavljevicDNikolicABone mineral density at different sites and vertebral fractures in Serbian postmenopausal womenClimacteric.201720374310.1080/13697137.2016.125305427860483Open DOISearch in Google Scholar
Rentero ML, Carbonell C, Casillas M, Bejar MG, Berenguer R. Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire. Open Rheumatol J. 2008;2:58-63. 10.2174/1874312900802010058.RenteroMLCarbonellCCasillasMBejarMGBerenguerR.Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaireOpen Rheumatol J.20082586310.2174/1874312900802010058258809119088873Open DOISearch in Google Scholar
Thomas CC, Zeytinoglu M. Primary care endocrinology in the adult woman. Obstet Gynecol Clin North Am. 2016;43:325-46. 10.1016/j.ogc.2016.01.005.27212095ThomasCCZeytinogluM.Primary care endocrinology in the adult womanObstet Gynecol Clin North Am.2016433254610.1016/j.ogc.2016.01.00527212095Open DOISearch in Google Scholar
